Navigation Links
Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
Date:7/7/2009

DALLAS, July 7 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today new preclinical data demonstrating that thiarabine shows remarkable efficacy in the prevention and treatment of rheumatoid arthritis (RA). In a well-established animal model for RA, an exceptional restoration of joint structure was observed in the studies, which were conducted at Wayne State University School of Medicine and at Southern Research Institute.

As a therapeutic treatment of established disease, thiarabine demonstrated a highly significant, dose-dependent amelioration of arthritis. Thiarabine treatment resulted in a broad inhibition of disease pathology, with reduction of both inflammatory and erosive disease parameters, as well as protection from loss of cartilage matrix proteins. When used as a preventative treatment, thiarabine blocked the development of joint disease at the 60 mg/kg/day dose level and exhibited a significant reduction in disease incidence and severity at 20 mg/kg/day.

In a therapeutic study comparing thiarabine to methotrexate, a commonly used clinical drug for RA treatment, high resolution 3-D images from an X-ray microtomograph were used along with histological scoring to evaluate joint and bone destruction. Thiarabine demonstrated statistically significant anti-arthritic efficacy comparable to that of methotrexate. "The images from X-ray microtomography present a compelling visual representation of diseased vs. treated limbs" commented David Nowotnik, Senior Vice President Research and Development. "We are delighted with the results of the preclinical study which demonstrate a real benefit to the use of thiarabine in RA."

"Our current development focus for thiarabine is for the treatment of hematological cancers," stated Jeffrey B. Davis, President & CEO. "But
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
2. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
3. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
6. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
7. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
8. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
11. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/1/2014)... Oct. 31, 2014 Research and Markets ... Prenatal Testing Market, Test Volume & Forecast" report ... the non-invasive prenatal test (NIPT) has transformed the prenatal ... how pregnancies are managed. Non-invasive prenatal genetic testing (NIPT) ... rapidly adopted in the US and in parts of ...
(Date:11/1/2014)... PHILADELPHIA , Oct. 31, 2014  Medical device companies EBI, ... of Indiana , have agreed to pay ... that they used kickbacks to induce physicians to purchase the companies, ... a whistleblower complaint filed by a former employee of Biomet, Yue ... False Claims Act. Ross Feller Casey , LLP, ...
(Date:11/1/2014)... 2014 Hologic, Inc. (NASDAQ: HOLX ... Medicaid Services (CMS) has released reimbursement rates for screening ... payment rates for the Category I Current Procedural Terminology ... new add-on Healthcare Common Procedure Coding System (HCPCS) code ... payment rates will go into effect January 1, 2015 ...
Breaking Medicine Technology:Global Non-Invasive Prenatal Testing Market, Test Volume & Forecast 2Global Non-Invasive Prenatal Testing Market, Test Volume & Forecast 3Biomet to Pay Over $6 Million to Resolve Whistleblower Claims That It Paid Kickbacks to Doctors 2The Centers for Medicare and Medicaid Services Issues Ruling on 2015 Reimbursement Rates 2The Centers for Medicare and Medicaid Services Issues Ruling on 2015 Reimbursement Rates 3The Centers for Medicare and Medicaid Services Issues Ruling on 2015 Reimbursement Rates 4
... CITY, Calif., Aug. 9, 2011 Cardica, Inc. (Nasdaq: ... fourth quarter and year ended June 30, 2011. Cardica,s management ... today to discuss the financial results and provide an update ... 30 has now been used successfully in multiple laparoscopic procedures ...
... CAMBRIDGE, Mass., Aug. 9, 2011 Theramed Corporation, Glenveigh ... website on critical childbirth complications at http://www.jetty.ca . ... jetty™, two newly developed medical devices used in advancing ... Jetty.ca offers comprehensive resources for both patients and physicians. ...
Cached Medicine Technology:Cardica Announces Fiscal 2011 Fourth Quarter and Year End Financial Results 2Cardica Announces Fiscal 2011 Fourth Quarter and Year End Financial Results 3Cardica Announces Fiscal 2011 Fourth Quarter and Year End Financial Results 4Cardica Announces Fiscal 2011 Fourth Quarter and Year End Financial Results 5Jetty.ca Features Essential Patient and Physician Resources for Critical Childbirth Complications 2
(Date:10/31/2014)... (PRWEB) October 31, 2014 Springboard ... for its small scale BioPro™ biodiesel processors, announced ... will further improve the performance and efficiency of ... GL95/MC12/BD380 trio will recover more than ... in with the glycerin by-product produced while making ...
(Date:10/31/2014)... The Memory Healer review published by DailyGossip.org reveals that ... suffered from Alzheimer's disease. , In fact, Alexander Lynch ... disease. His father pointed a gun and shot him during ... author of this method understood that he needed to do ... program is based on years of research. The author of ...
(Date:10/31/2014)... 2014 At the start of 2014, ... escaping carbon monoxide poisoning in their homes. Now, as ... one family-owned, Missouri-based heating and cooling company is taking ... families start the home heating season with the assurance ... , Beginning Nov. 1, 2014, E and Q Heating ...
(Date:10/31/2014)... Oct. 31, 2014 (HealthDay News) -- Surgery for low ... where in the United States you live, a new ... experience low back pain at some point in their ... professional medical care for a spine problem," co-author Brook ... Clinical Practice, said in a college news release. ...
(Date:10/31/2014)... insomnia is a major contributor to deaths caused by ... results underscore the importance of the "Sleep Well, Be ... , Results show that the risk of unintentional fatal ... of insomnia symptoms present. People with all three symptoms ... from a fatal injury than those with no insomnia ...
Breaking Medicine News(10 mins):Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 2Health News:Springboard Biodiesel Announces Release of New and Unique Methanol Recovery and Glycerin Treatment Equipment 3Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 2Health News:Many Homeowners Missing Key Safety Risks with Home Heating;Missouri-based Company E and Q Announces New Safety Check 3Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Insomnia increases risk of motor vehicle deaths, other fatal injuries 2
... Congratulate Players, MCKINNEY, Texas, Nov. 10 ... cards last night following the,Nationwide Tour Championship at ... PGA TOUR,s newest official marketing,partner, hosted a celebratory ... for their achievement., "This class adds to ...
... to spur cancer,s growth could actually hinder rather than ... the University of California, San Diego. , The findings ... strangling its blood supply have been disappointing when used ... combined with traditional chemotherapy. , Despite their rapid progression, ...
... Cancer cells are already stressed by the fast pace they require ... just may kill them. , "Think about an assembly line in ... Dr. Kapil Bhalla, director of the Medical College of Georgia ... workers to keep going. Some of them fall out, some get ...
... Pennsylvania Facilities Meet Federal Standards, HARRISBURG, Pa., ... reports today showing that all of the 76,mammography ... this year,are operating within the guidelines set forth ... inspects each of Pennsylvania,s approximately 400 certified,mammography facilities ...
... to present results from Phase 1/2 Clinical Trial of,Perifosine ... 2008 at 8:30am, NEW YORK, Nov. 10 ... data from its Phase 1/2 clinical,trial of KRX-0401 (perifosine) ... Annual Meeting of the American Society of Hematology,(ASH), to ...
... NEW YORK, Nov. 10 The American Society ... (RPR) to educate the public on the interventional ... use to,relieve pain., Founded in 1998, ASIPP ... all interventional pain physicians. ASIPP members are board,certified ...
Cached Medicine News:Health News:Top 25 Nationwide Tour Players Earn PGA TOUR Cards for 2009 Season 2Health News:Top 25 Nationwide Tour Players Earn PGA TOUR Cards for 2009 Season 3Health News:Tumors grow faster without blood-supply promoting molecule 2Health News:Researchers aim to over-stress already taxed mantle cell lymphoma cells 2Health News:Researchers aim to over-stress already taxed mantle cell lymphoma cells 3Health News:DEP Releases Third Quarter Mammography Inspections 2Health News:DEP Releases Third Quarter Mammography Inspections 3Health News:Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology 2Health News:Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology 3Health News:Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology 4Health News:Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology 5Health News:Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology 6Health News:Rubenstein Public Relations to Launch National Campaign for The American Society of Interventional Pain Physicians 2
For use with E0828 needle and gouge set and E0828 C handle. Straight gouge shape tip. Polished finish. Most popular size or model....
Set consists of one each:E0824 A replacement burr set. E0824 B handle....
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle....
Taper with blunt tip. Stainless steel. Round knurled handle with polished finish. Taper : Long 32 mm. Overall length: 3.9 inches. Most popular size or model....
Medicine Products: